[1] |
Calderone R,Sun N,Gay-Andrieu F,et al.Antifungal drug discovery:The process and outcomes[J].Future Microbiology,2014,9(6):791-805.
|
[2] |
Liu You-ning, Fang Xiang-qun.Antifungal drugs and their clinical applications[J].Chinese Journal of Tuberculosis and Respiratory Diseases,2006,29(5):298-299.(in Chinese)
|
[3] |
Brown G D,Denning D W,Gow N A R,et al.Hidden killers:Human fungal infections[J].Science Translational Medicine,2012,4(165):165rv13.
|
[4] |
Brown E D, Wright G D. Antibacterial drug discovery in the resistance era[J].Nature,2016,529(7586):336-343.
|
[5] |
Chowdhary A,Sharma C,Meis J F.Candida auris:A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally[J].PLoS Pathogens,2017,13(5):e1006290.
|
[6] |
Lamb J, Crawford E D, Peck D, et al.The connectivity MAP:Using gene-expression signatures to connect small molecules,genes,and disease[J].Science,2006,313(5795):1929-1935.
|
[7] |
Qiaonan D N, Flynn C, Niepel M, et al.LINCS Canvas browser:Interactive web app to query,browse and interrogate LINCS L1000 gene expression signatures[J].Nucleic Acids Research, 2014,42(W1):W449-W460.
|
[8] |
Qu X A,Rajpal D K.Applications of connectivity map in drug discovery and development[J].Drug Discovery Today,2012,17(23-24):1289-1298.
|
[9] |
Scannell J W, Blanckley A, Boldon H, et al. Diagnosing the decline in pharmaceutical R&D efficiency[J]. Nature Review Drug Discovery,2012,11(3):191-200.
|
[10] |
Wang Ke-jian, Shi Le-ming,He Lin,et al.New opportunities for Chinese pharmaceutical R&D: Systematic drug repurposing based on big data[J].Chinese Science Bulletin,2014,59(18):1490-1796.(in Chinese)
|
[11] |
Ashburn T T,Thor K B.Drug repositioning:Identifying and developing new uses for existing drugs[J].Nature Reviews Drug Discovery,2004,3(8):673-683.
|
[12] |
Wheeler D L, Barrett T, Benson D A,et al.Database resources of the national center for biotechnology information[J].Nucleic Acids Research,2007,35(Suppl-1):D5-D12.
|
[13] |
Whirl-Carrillo M,McDonagh E M,Hebert J M,et al.Pharmacogenomics knowledge for personalized medicine[J].Clinical Pharmacology & Therapeutics,2012,92(4):414-417.
|
[14] |
Wishart D S,Knox C,Guo A C,et al.DrugBank:A know- ledge base for drugs,drug actions and drug targets[J].Nucleic Acids Research, 2008,36(Database issue):D901-D906.
|
[15] |
Berman H M,Westbrook J,Feng Z,et al.The protein data bank[J]. Nucleic Acids Research,2000,28(1):235-242.
|
[16] |
Iorio F,Bosotti R,Scacheri E,et al.Discovery of drug mode of action and drug repositioning from transcriptional respons- es[J].Proceedings of the National Academy of Sciences,2010,107(33):14621-14626.
|
[17] |
Rohan L,Neil S,Mark B,et al.Transcriptomics technologies[J].PLOS Computational Biology,2017,13(5):e1005457.
|
[18] |
Huang Xin, He Song, Liu Yang,et al.LINCS—Cellular response big data project for translational medicine[J].Progress in Biochemistry and Biophysics,2017,44(11):1041-1043.(in Chinese)
|
[19] |
Subramanian A, Narayan R, Corsello S M, et al. A next generation connectivity map:L1000 Platform and the First 1,000,000 Profiles[J].Cell,2017,171(6):1437-1452.
|
[20] |
Keenan A B, Jenkins S L, Jagodnik K M, et al. The library of integrated network-based cellular signatures NIH program:System-level cataloging of human cells response to perturbations[J].Cell Systems,2018,6(1):13-24.
|
[21] |
Subramanian A,Tamayo P,Mootha V K,et al.Gene set enrichment analysis:A knowledge-based approach for interpreting genome-wide expression profiles[J].Proceedings of the National Academy of Sciences,2005,102(43):15545-15550.
|
[22] |
Pihur V,Datta S,Datta S.RankAggreg,an R package for weighted rank aggregation[J].BMC Bioinformatics,2009,10:62.
|
[23] |
Glaser K B,Staver M J,Waring J F,et al.Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors:Defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines[J].Molecular Cancer Therapeutics,2003,2:151-163.
|
[24] |
Gentleman R C,Carey V J,Bates D M,et al.Bioconductor:Open software development for computational biology and bioinformatics[J].Genome Biology,2004,5:R80.
|
[25] |
Smirnov P,Safikhani Z,El-Hachem N,et al.PharmacoGx:An R package for analysis of large pharmacogenomic datasets[J].Bioinformatics,2016,32(8):1244-1246.
|
[26] |
Durinck S,Moreau Y,Kasprzyk A,et al.BioMart and Bioconductor:A powerful link between biological databases and microarray data analysis[J].Bioinformatics,2005,21(16):3439-3440.
|
[27] |
Carrillo-Muoz A J, Giusiano G,Ezkurra P A,et al.Sertaconazole:Updated review of a topical antifungal agent[J].Expert Review of Anti Infective Therapy,2005,3(3):333-342.
|
[28] |
Zeng Bei-ni.Study on the effect of suloctidil on the formation and growth of Candida albicans biofilm[D].Jinan:Shandong University,2017.(in Chinese)
|
|
附中文参考文献:
|
[2] |
刘又宁,方向群.抗真菌药物及其临床应用[J].中华结核和呼吸杂志,2006,29(5):298-299.
|
[10] |
王可鉴,石乐明,贺林,等.中国药物研发的新机遇:基于医药大数据的系统性药物重定位[J].科学通报,2014,59(18):1790-1796.
|
[18] |
黄昕,何松,刘阳,等.LINCS——面向转化医学的细胞反应大数据计划[J].生物化学与生物物理进展,2017,44(11):1041-1043.
|
[28] |
曾贝妮.舒洛地尔对白假丝酵母菌生物被膜形成及生长的作用研究[D].济南:山东大学,2017.
|